Is a complete FRA/8CC research report available?

No complete published report is available for fra/8CC (FRA/8CC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/8CC (FRA/8CC)

Frankfurt Stock Exchange: FRA/8CC · EUR

€0.74

-0.06 (-7.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/8CC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	10.5M
Revenue (ttm)	195.1K
Net income (ttm)	-7.7M
EPS (ttm)	-€0.63
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 195.1K
Net income (ttm): -7.7M
EPS (ttm): -€0.63
Market cap: 10.5M

All FRA/8CC indicators

Market & fundamental data

Available fields

148

Groups with data

Currency

USD

Showing 148 of 148 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	10
Employees Change	-1%
Employees Change Percent	-9.09
Enterprise value	EUR 7.7M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-07-31
Market cap	EUR 10.5M
Price	EUR 0.74
Price currency	EUR
Rev Per Employee	19,514.3x
Sic	2834
Symbol	fra/8CC
Website	https://www.cocrystalpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-72.63%
EV/Sales	38.84x
FCF yield	-62.56%
P/B ratio	2.95x
P/S ratio	54.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -4.2M
Net Income	EUR -7.7M
Pretax Margin	-3,923.99%
Profit Per Employee	EUR -765,739
ROA	-62.44
Roa5y	-33.5
ROCE	-173.8
ROE	-154.6
Roe5y	-70.31
ROIC	-77.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-41.13%
Cagr3y	-29.61%
Revenue Growth5 Y	-32.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.02
Assets	EUR 6.4M
Cash	EUR 4.1M
Current Assets	EUR 5.2M
Current Liabilities	EUR 1.9M
Debt	EUR 1.2M
Debt Equity	EUR 0.35
Debt FCF	EUR -0.19
Equity	EUR 3.6M
Liabilities	EUR 2.9M
Long Term Assets	EUR 1.3M
Long Term Liabilities	EUR 937,469
Net Cash	EUR 2.8M
Net Cash By Market Cap	EUR 26.82
Net Cash Growth	-37.14%
Net Debt Equity	EUR -0.79
Tangible Book Value	EUR 3.6M
Tangible Book Value Per Share	EUR 0.26

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.66
Net Working Capital	EUR -548,134
Quick ratio	2.44
Working Capital	EUR 3.2M
Working Capital Turnover	EUR 0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-41.11%
200-day SMA	0.91
3Y total return	-65.13%
50-day SMA	0.86
50-day SMA vs 200-day SMA	50under200
All Time High	3.03
All Time High Change	-73.76%
All Time High Date	2022-11-15
All Time Low	0.71
All Time Low Change	12.77%
All Time Low Date	2026-02-06
ATR	0.01
Ch YTD	-1.24
High	0.74
High52	2.8
High52 Date	2025-09-12
High52ch	-73.75%
Low	0.74
Low52	0.71
Low52 Date	2026-02-06
Low52ch	4.26%
Ma50ch	-7.23%
Price vs 200-day SMA	-12.54%
RSI	40.97
RSI Monthly	40.12
RSI Weekly	41.46
Sharpe ratio	-0.36x
Sortino ratio	-0.57
Total Return	-19.85%
Tr YTD	-1.24
Tr1m	-7.02%
Tr1w	0.63%
Tr3m	-31.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -7.8M
Operating margin	-4,015.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,124,988%
Shares Insiders	33.82%
Shares Institutions	5.3%
Shares Qo Q	-0.2%
Shares Yo Y	19.85%
Short Ratio	4.44

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -6.8M
Adjusted OCF	-6,821,315
Average Volume	0x
Bv Per Share	0.26
CAPEX	EUR -10,408
Ch1m	-7.02
Ch1w	0.63
Ch1y	-41.11
Ch3m	-31.47
Ch3y	-65.13
Ch6m	-3.64
Change	-7.55%
Change From Open	0
Close	0.8
Days Gap	-7.55
Depreciation Amortization	51,172.9
Earnings Date	2026-08-11
EBIT	EUR -7.8M
EBITDA	EUR -7.8M
EPS	EUR -0.63
F Score	1
FCF	EUR -6.6M
FCF EV Yield	-85.9x
Financing CF	4,656,534
Fiscal Year End	December
Founded	2,006
Investing CF	-10,408
Is Primary Listing	0
Last Earnings Date	2025-11-21
Last Report Date	2026-03-31
Ma150	0.92
Ma150ch	-13.34%
Ma20	0.82
Ma20ch	-3.46%
Net CF	-1,939,283
Next Earnings Date	2026-08-11
Open	0.74
Ppne	1,207,333.1
Price Date	2026-07-30
Ptbv Ratio	2.95
Relative Volume	20x
Revenue	195,143x
SBC By Revenue	120.89x
Share Based Comp	235,906
Tr6m	-3.64%
Volume	0
Z Score	-65.62

FRA/8CC (FRA/8CC)

Coverage state: Market snapshot only — no published research

Generate the first FRA/8CC analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/8CC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/8CC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/8CC

Frequently asked questions